For instance, miR-30b and miR-30c can predict the response to tyrosine kinase inhibitors in NSCLC, while miRNA-20a promotes chemoresistance in NSCLC through the PTEN/PI3K-AKT pathway [169, 170]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.